Examining the Experiences of Children With Blood Disorders

Venous Thromboembolism Clinical Trial

Official title: Examining the Experiences of Children With Blood Disorders

Status Recruiting

Clinical Trial Summary

This is a 3-phase mixed methods study design. A literature review (Phase 1) has been completed to determine the areas of exploration and to identify challenges faced and the impact of the blood disorder on pediatric patients. Based on Phase 1, Phases 2 and 3, as proposed in this study, will be completed and will include interviews of patients diagnosed with bleeding and thrombotic disorders (phase 2). The interviews will be individual, semi-structured, and consist of open-ended questions to elicit unbiased and in-depth responses to gain an understanding of participant's perspectives on themes predetermined in the study design phase.

Clinical Trial Description

The purpose of this study is to explore the experiences of pediatric patients with blood disorders, specifically thrombotic, including venous thromboembolism (VTE), and hemostatic or bleeding disorders. The information gleaned from this study will help identify specific challenges faced by patients with hemostatic and thrombotic disorders - information that is necessary to develop impactful, evidence-based solutions to support patients with hemostatic and thrombotic disorders cope with the physical, emotional, and psychological impact of blood disorders. Participants with blood disorders in this study will participate in open-ended, semi-structured interviews with a study investigator focusing on the psychosocial experiences of patients with diagnosis and treatment of their underlying disorder and the understanding of their diagnosis. Female participants additionally will be asked questions about the unique effects of heavy menstrual bleeding, either from their underlying blood disorder or secondary to anticoagulation, on similar aspects of the impact of having a blood disorder. Validated questionnaires will be completed to obtain concurrent quantitative data. The interviews will be recorded and transcribed. Participation is complete after the interview has finished; participants will continue to receive standard of care treatment during and beyond the study period. ;

Related Conditions & MeSH terms

• Bleeding Disorder
• Blood Coagulation Disorders
• Blood Disease
• Hematologic Diseases
• Hemostatic Disorder
• Hemostatic Disorders
• Thromboembolism
• Thrombosis
• Thrombotic Disorder
• Venous Thromboembolism

• NCT number: NCT04600609
• Study type: Observational
• Source: University of Texas Southwestern Medical Center
• Contact: Ayesha Zia, MD
• Phone: 214-456-7000
• Email: Ayesha.Zia@utsouthwestern.edu
• Status: Recruiting
• Start date: November 9, 2020
• Completion date: December 2025